NEUROACTIVE STEROID FOR THE TREATMENT OF HUNTINGTON'S DISEASE
Provided herein are methods for improving working memory and/or executive function in a subject suffering from Huntington's Disease, comprising administering to the subject SAGE-718, an investigational positive allosteric modulator of the NMDA receptor. La présente invention concerne des méthod...
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
22.06.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Provided herein are methods for improving working memory and/or executive function in a subject suffering from Huntington's Disease, comprising administering to the subject SAGE-718, an investigational positive allosteric modulator of the NMDA receptor.
La présente invention concerne des méthodes destinées à améliorer la mémoire de travail et/ou la fonction exécutive chez un sujet souffrant de la maladie de Huntington, comprenant l'administration au sujet de SAGE-718, un modulateur allostérique positif d'investigation du récepteur NMDA. |
|---|---|
| AbstractList | Provided herein are methods for improving working memory and/or executive function in a subject suffering from Huntington's Disease, comprising administering to the subject SAGE-718, an investigational positive allosteric modulator of the NMDA receptor.
La présente invention concerne des méthodes destinées à améliorer la mémoire de travail et/ou la fonction exécutive chez un sujet souffrant de la maladie de Huntington, comprenant l'administration au sujet de SAGE-718, un modulateur allostérique positif d'investigation du récepteur NMDA. |
| Author | QUIRK, Michael C KOENIG, Aaron Michael |
| Author_xml | – fullname: QUIRK, Michael C – fullname: KOENIG, Aaron Michael |
| BookMark | eNrjYmDJy89L5WSw9XMNDfJ3dA7xDHNVCA5xDfL3dFFw8w9SCPFwVQgJcnUM8XX1C1Hwd1PwCPUL8fRzD_H3Uw9WcPEMdnUMduVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHh_kYGRsaGhiaGpkaOhsbEqQIAABAskg |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | STÉROÏDE NEUROACTIF POUR LE TRAITEMENT DE LA MALADIE DE HUNTINGTON |
| ExternalDocumentID | WO2023114152A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_WO2023114152A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Oct 04 05:02:51 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_WO2023114152A13 |
| Notes | Application Number: WO2022US52596 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230622&DB=EPODOC&CC=WO&NR=2023114152A1 |
| ParticipantIDs | epo_espacenet_WO2023114152A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20230622 |
| PublicationDateYYYYMMDD | 2023-06-22 |
| PublicationDate_xml | – month: 06 year: 2023 text: 20230622 day: 22 |
| PublicationDecade | 2020 |
| PublicationYear | 2023 |
| RelatedCompanies | SAGE THERAPEUTICS, Inc |
| RelatedCompanies_xml | – name: SAGE THERAPEUTICS, Inc |
| Score | 3.4648676 |
| Snippet | Provided herein are methods for improving working memory and/or executive function in a subject suffering from Huntington's Disease, comprising administering... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | NEUROACTIVE STEROID FOR THE TREATMENT OF HUNTINGTON'S DISEASE |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230622&DB=EPODOC&locale=&CC=WO&NR=2023114152A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fS8MwED7GFPVNp-KPKQGlPhVr1s69DNna1E5YO9Zs7m2kbQaCdMNV_Pe9K53uaW_5ASEJXO77LpcvAPdWxnXW6mRmm2JMtm2lJjpBbSplaeWkTwihKd4xDNvBxH6bObMafG7ewpQ6oT-lOCJaVIr2XpTn9eo_iOWVuZXrx-QDm5Yvvux6RsWOCU9zbnj9rhhFXuQarou8zQjHZR9Cf_RWPeRKewSkSWlfTPv0LmW17VT8Y9gf4Xh5cQI1nTfg0N38vdaAg2F15Y3FyvrWp9ANKe-O0j6mgsWIQ6OBx5DFMRkIJseiJ0mZn0U-CyahHISvMgofYuYNYtGLxRnc-UK6gYnzmP8te_4ebU-6dQ71fJnrC2C6RSp5tuKOUsjHFsmCW1lCXC597iTauoTmrpGudndfwxFVKR2K8ybUi69vfYOOt0huy_36Ba7ZgC0 |
| link.rule.ids | 230,309,786,891,25594,76906 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKc43nYqXqQGlPhVr1l1einRtaqtbOtZs7m30koEg3XAV_74nZdM97S3kQEgCJ-f7Tk6-ANwbGZVZs5vpbZVjMk0j1TEISj2ODRm30ieE0CrfMeBtf2y-TlvTCnxu3sKUOqE_pTgielSK_l6U5_XyP4nllrWVq8fkA7sWz56wXG3NjhWeplRzexYbhm7oaI6DvE3jo9KG0B-jlY1caa-j9HkVeJr01LuU5XZQ8Y5gf4jj5cUxVGReh5qz-XutDgeD9ZU3NtfetzoBi6u6O1X2MWEkQhwaBi5BFkeEz4gYMVsoZX4SesQfcxHwFxHyh4i4QcTsiJ3CnceE4-s4j9nfsmfv4fakm2dQzRe5PAcim0olz4xpK46Rj82TOTWyRHG5tNNNpHEBjV0jXe4230LNF4P-rB_wtys4VCZVGkVpA6rF17e8xiBcJDfl3v0C1eiDGg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NEUROACTIVE+STEROID+FOR+THE+TREATMENT+OF+HUNTINGTON%27S+DISEASE&rft.inventor=QUIRK%2C+Michael+C&rft.inventor=KOENIG%2C+Aaron+Michael&rft.date=2023-06-22&rft.externalDBID=A1&rft.externalDocID=WO2023114152A1 |